This website is intended exclusively for healthcare professionals residing and/or working in the UAE.
Prof. Rich Bergenstal, endocrinologist and executive director of international Diabetes Center at Health Partners, Minneapolis, presenting glucose variability with second-generation basal insulin analogs Glargine 300 U/ml and Degludec 100 U/ml evaluated by CGM in people with T1DM based on the InRange randomized controlled trial.
MAT-BH-2200730/V1/Sep2022
By clicking on this link, you will be leaving Campus Sanofi website and going to another, entirely independent website.
Please note: Sanofi provides these links as a service to its website visitors and users; however, Sanofi takes no responsibility for the information on any website but their own.